10x Genomics Operating Income 2018-2024 | TXG

10x Genomics operating income from 2018 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

10x Genomics Operating Income 2018-2024 | TXG

10x Genomics operating income from 2018 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$8.5B
Inspire Medical Systems (INSP)$5.3B
Hims & Hers Health (HIMS)$5.1B
Privia Health (PRVA)$2.5B
Enovis (ENOV)$2.5B
IRhythm Technologies (IRTC)$2.4B
Azenta (AZTA)$2B
Omnicell (OMCL)$2B
Clover Health Investments (CLOV)$1.6B
Schrodinger (SDGR)$1.4B
Phreesia (PHR)$1.1B
Butterfly Network (BFLY)$650M
Standard BioTools (LAB)$562M
Talkspace (TALK)$522M
Fulgent Genetics (FLGT)$520M
Definitive Healthcare (DH)$483M
Health Catalyst (HCAT)$459M
TruBridge (TBRG)$244M
Pulmonx (LUNG)$237M
SOPHiA GENETICS SA (SOPH)$214M
American Well (AMWL)$122M
EUDA Health Holdings (EUDA)$107M
P3 Health Partners (PIII)$75M
HeartBeam (BEAT)$67M
111 (YI)$53M
CareCloud (CCLD)$46M
Zepp Health (ZEPP)$40M
SHL Telemedicine (SHLT)$40M
Outset Medical (OM)$39M
Movano (MOVE)$20M